Global Rapid Diagnostics Market 2018-2022 - Growing Presence of OEMs / Use of Digital Health in Rapid Diagnostics for POC / Increasing Number of M&A

DUBLIN, March 14, 2018 /PRNewswire/ --

The "Global Rapid Diagnostics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The global rapid diagnostics market to grow at a CAGR of 7.56% during the period 2018-2022.

Global Rapid Diagnostics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers for this market is Increasing incidence of chronic and infectious diseases. Various chronic diseases such as heart diseases, diabetes, stroke, cancers, obesity, and kidney diseases are increasing across the globe which resulted in the greater demand for diagnostic procedures like rapid diagnostics and technologically advanced treatment options. These chronic diseases can be easily diagnosed using point of care (POC) products.

The latest trend gaining momentum in the market is Growing presence of OEMs. The OEM provides equipment's to the manufacturers that develop, distribute, and sell the final furnished goods. Generally, OEM develops certain components of the products however, sometimes the OEM may manufacture complete device. The OEMs are working with contract manufacturing organizations (CMOs) due to increasing number of combination products such as drug delivery and smart devices. There is growing focus towards forward integration by the OMEs involved in providing diagnostics components.

Further, the report states that one of the major factors hindering the growth of this market is High cost of rapid diagnostic products. The rapid diagnostics products such as analyzers, assays and frequent usage of the consumables and reagents are associated with higher costs which are incurred by the end user such as hospitals, clinics, diagnostics laboratories. Moreover, POC diagnostics test products have faster turnaround time (TAT) which leads to high cost however, the testing products other than POC cost are comparatively lower.

Key vendors

• Abbott
• BD
• bioMrieux
• Danaher
• F. Hoffmann-La Roche
• Siemens Healthcare
  

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING

• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION

• Segmentation by application
• Comparison by application
• Blood glucose testing- Market size and forecast 2017-2022
• Cardiometabolic testing - Market size and forecast 2017-2022
• Infectious disease testing - Market size and forecast 2017-2022
• Pregnancy and fertility testing - Market size and forecast 2017-2022
• Fecal occult testing - Market size and forecast 2017-2022
• Toxicology testing - Market size and forecast 2017-2022
• Coagulation testing - Market size and forecast 2017-2022
• Market opportunity by application

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER

• Segmentation by end-user
• Hospitals and clinics
• Clinical diagnostic laboratories
• Home care settings

PART 10: REGIONAL LANDSCAPE

• Geographical segmentation
• Regional comparison
• Rapid diagnostics market in Americas
• Rapid diagnostics market in EMEA
• Rapid diagnostics market in APAC
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 13: MARKET TRENDS

• Growing presence of OEMs
• Use of digital health in rapid diagnostics for POC
• Increasing number of M&A

PART 14: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive landscape

PART 15: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• BD
• bioMrieux
• Danaher
• F. Hoffmann-La Roche
• Siemens Healthcare
• Other prominent vendors

PART 16: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/cl5kql/global_rapid?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets